[3] The combination of potent weight loss and glucose control underscores retatrutides potential as a dual-purpose treatment for metabolic disorders, addressing both adiposity and insulin resistance in a single medication
Going off a GLP-1 short for glucagon-like peptide-1 receptor agonist isnt without potential consequences
Retatrutide is not FDA-approved for weight loss or any other treatment at this time
Dosing and Administration Recommended Dosages GLP-1 agonists come in various dosage forms and strengths, with specific recommendations for each medication
So while we arent comparing apples to apples when comparing GLP-1 stimulated via diet versus a GLP-1 from medication, we also know that not everyone can take a GLP-1 medication
It made this list because of this potential, but due to prohibitive contracts, poor customer service, and a buggy app, WeightWatchers still has room for improvement